The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to: * Improved compliance with prescribed inhaler use * Improved technique of inhaler use * A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage. * An improvement in patient quality of life scores
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
152
Feedback on the patient's own inhaler use, with personalized information on the patients technique and timing of use of the diskus inhaler as recorded on the INCA device will be provided to patients in the feedback group after 1,2 and 6 months.
Feedback on the patient's own inhaler technique as observed by pharmacist and education to support best use will be provided to patients in the demonstration group after 1,2 and 6 months.
Boots Retail (Ireland) Limited
Dublin, Ireland
Rate of adherence
The rate of adherence is the proportion of correctly taken drugs at the correct time relative to the prescribed interval.
Time frame: 2 months and 6 months
Rescue inhaled medication use
Time frame: Six months
Rescue antibiotic and/or steroid medication use
Time frame: 6 months
Quality of life
Time frame: 2 months and 6 months
Adherence in the time domain
Time frame: Two months and six months
Technique adherence
Time frame: Two months and six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.